Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 49, 5555-5560, October 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Yu, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Yu, A. L.

Induction of Erythroid Differentiation in K562 Cells by Inhibitors of Inosine Monophosphate Dehydrogenase1

John Yu2, Victor Lemas, Theodore Page, James D. Connor and Alice L. Yu

Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, California 92037 [J. Y., V. L.], and Department of Pediatrics, University of California at San Diego, La Jolla, California 92093 [T. P., J. D. C., A. L. Y.]

The effects of three inhibitors of inosine monophosphate (IMP) dehydrogenase on a human erythroleukemic cell line, K562, were studied. Following incubation with these inhibitors, K562 cells underwent differentiation and accumulated hemoglobins. The induction of hemoglobin accumulation was dose dependent; maximum induction was observed at 100, 25, and 3 µM, respectively, for ribavirin, tiazofurin, and mycophenolic acid. The induction was associated with reduction of intracellular GTP content and was blocked by adding guanosine within 24 h after adding inducer. The effective dose for half-maximum induction by ribavirin was 3 times less than that for 50% inhibition of K562 proliferation; however, for tiazofurin and mycophenolic acid, it closely approximated the concentrations which suppressed cellular proliferation. Ribavirin was sequestered preferentially inside the K562 cells, and the induction by ribavirin had a greater than 30-fold increase in hemoglobin. Studies with isoelectric focusing, globin chain analyses, and immunochemical assays indicated that both A{gamma} and G{gamma} were detected and that the hemoglobin produced in the ribavirin-treated cells consisted of approximately 60% fetal hemoglobin and its acetylated equivalents. The adult-type {alpha} globin was found, while no ß globin chains were demonstrated. Thus, accumulation of fetal hemoglobin and production of {alpha} globin chain in ribavirin-treated cells are different from the pattern of hemoglobins induced by hemin.

1 This work was supported in part by grants from the NIH (DK 37039 and CA 40186). This is Publication 5408-BCR from the Research Institute of Scripps Clinic, La Jolla, Ca.

2 To whom requests for reprints should be addressed at Department of Basic and Clinical Research, BCR3, Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, CA 92037.

Received 6/13/88. Revised 11/ 4/88. Revised 4/17/89. Revised 7/ 7/89. Accepted 7/20/89.




This article has been cited by other articles:


Home page
BloodHome page
J. J. Gu, K. Gathy, L. Santiago, E. Chen, M. Huang, L. M. Graves, and B. S. Mitchell
Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion
Blood, June 15, 2003; 101(12): 4958 - 4965.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Barnes, R. A. Izydore, A. E. Eakin, and I. H. Hall
Induction of Tmolt4 Leukemia Cell Death by 3,3-Disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Specificity for Type II Inosine 5'-Monophosphate Dehydrogenase
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 790 - 796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Gu, J. Spychala, and B. S. Mitchell
Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene. UTILIZATION OF ALTERNATIVE PROMOTERS
J. Biol. Chem., February 14, 1997; 272(7): 4458 - 4466.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1989 by the American Association for Cancer Research.